U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H10Cl2N2O
Molecular Weight 305.159
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DELORAZEPAM

SMILES

ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3Cl)C2=C1

InChI

InChIKey=CHIFCDOIPRCHCF-UHFFFAOYSA-N
InChI=1S/C15H10Cl2N2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)

HIDE SMILES / InChI
Delorazepam is a benzodiazepine with anxiolytic effects. It is a metabolite of the designer drug diclazepam that can be detected in either the serum or urine. Delorazepam can also be produced by enzymatic treatment of lorazepam with β-glucuronidase. It is indicated for the treatment of anxiety, tension and other somatic or psychiatric manifestations associated with anxiety syndrome, insomnia. The side effects and precautions for use of delorazepam are the same as for all benzodiazepines, in particular as regards the development of dependence (mental and physical) and tolerance. Prolonged use may lead to difficulties remembering recent names and events (anterograde amnesia). It has been approved for marketing in Italy.

Approval Year

PubMed

PubMed

TitleDatePubMed
Quantification of chlordesmethyldiazepam by liquid chromatography-tandem mass spectrometry: application to a cloxazolam bioequivalence study.
2009-12
Treatment with aripiprazole and topiramate in an obese subject with borderline personality disorder, obsessive-compulsive symptoms and bulimia nervosa: a case report.
2009-07-23
GABA(A) receptors in normal development and seizures: friends or foes?
2008-03
An observational study in psychiatric acute patients admitted to General Hospital Psychiatric Wards in Italy.
2007-01-27
SPME-LC with UV detection to study delorazepam-serum albumin interactions.
2002-07-31
Determination of delorazepam in urine by solid-phase microextraction coupled to high performance liquid chromatography.
2002-06-01
Psychotic affective disorder after nicotine withdrawal.
1994-03
Participation of GABAergic mechanisms in the hypotensive and bradycardic effects of clonidine: experimental study in conscious normotensive and hypertensive rats.
1987-10
Patents

Sample Use Guides

Anxiety: 1 tablet of 0.5-1 mg 2-3 times a day Insomnia: 1 tablet of 0.5-1-2 mg in the evening before bedtime.
Route of Administration: Oral
Name Type Language
DADUMIR
Preferred Name English
DELORAZEPAM
INN   MART.   WHO-DD  
INN  
Official Name English
CHLORDESMETHYLDIAZEPAM
Common Name English
7-CHLORO-5-(O-CHLOROPHENYL)-1,3-DIHYDRO-2H-1,4-BENZODIAZEPIN-2-ONE
Common Name English
DELORAZEPAM [MART.]
Common Name English
delorazepam [INN]
Common Name English
NSC-169895
Code English
Delorazepam [WHO-DD]
Common Name English
Classification Tree Code System Code
DEA NO. 2754
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
NCI_THESAURUS C1012
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C98132
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
WIKIPEDIA
DELORAZEPAM
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
CHEBI
111762
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
EVMPD
SUB06957MIG
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
SMS_ID
100000090622
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
ECHA (EC/EINECS)
220-771-9
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
NSC
169895
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
CAS
2894-67-9
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
FDA UNII
O91W32476G
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
DRUG BANK
DB01511
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
ChEMBL
CHEMBL268254
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
MESH
C013434
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
EPA CompTox
DTXSID70183137
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
INN
4510
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
PUBCHEM
17925
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY
DRUG CENTRAL
800
Created by admin on Mon Mar 31 18:00:17 GMT 2025 , Edited by admin on Mon Mar 31 18:00:17 GMT 2025
PRIMARY